Aug 3, 2018· Comment from National Association of Chain Drug Stores (NACDS)· FDA-2018-D-1041-0005
The National Association of Chain Drug Stores appreciates the opportunity to provide the attached comments on the Draft Guidance addressing Development of a Shared System Risk Evaluation and Mitigation Strategy (REMS) for multiple prescription drug and biological products. We thank FDA for considering our views on this matter.